USP18 and tuberculosis: Its expression was observed to increase during M. tb infection, and a study found that USP18 levels significantly rise in TB patients after isoniazid (INH) treatment, suggesting its potential as a marker for monitoring therapy response (De Oyarzabal et al., 2019).